These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
224 related items for PubMed ID: 32441006
1. Predictive model of surgical remission in acromegaly: age, presurgical GH levels and Knosp grade as the best predictors of surgical remission. Araujo-Castro M, Pascual-Corrales E, Martínez-Vaello V, Baonza Saiz G, Quiñones de Silva J, Acitores Cancela A, García Cano AM, Rodríguez Berrocal V. J Endocrinol Invest; 2021 Jan; 44(1):183-193. PubMed ID: 32441006 [Abstract] [Full Text] [Related]
2. Impact of tumor characteristics and pre- and postoperative hormone levels on hormonal remission following endoscopic transsphenoidal surgery in patients with acromegaly. Cardinal T, Rutkowski MJ, Micko A, Shiroishi M, Jason Liu CS, Wrobel B, Carmichael J, Zada G. Neurosurg Focus; 2020 Jun; 48(6):E10. PubMed ID: 32480366 [Abstract] [Full Text] [Related]
3. Endoscopic transsphenoidal surgery for acromegaly: remission using modern criteria, complications, and predictors of outcome. Jane JA, Starke RM, Elzoghby MA, Reames DL, Payne SC, Thorner MO, Marshall JC, Laws ER, Vance ML. J Clin Endocrinol Metab; 2011 Sep; 96(9):2732-40. PubMed ID: 21715544 [Abstract] [Full Text] [Related]
4. Endoscopic vs microsurgical transsphenoidal surgery for acromegaly: outcomes in a concurrent series of patients using modern criteria for remission. Starke RM, Raper DM, Payne SC, Vance ML, Oldfield EH, Jane JA. J Clin Endocrinol Metab; 2013 Aug; 98(8):3190-8. PubMed ID: 23737543 [Abstract] [Full Text] [Related]
5. Prognostic Factors of Acromegalic Patients with Growth Hormone-Secreting Pituitary Adenoma After Transsphenoidal Surgery. Taweesomboonyat C, Oearsakul T. World Neurosurg; 2021 Feb; 146():e1360-e1366. PubMed ID: 33309643 [Abstract] [Full Text] [Related]
6. Treatment of acromegaly by endoscopic transsphenoidal surgery: surgical experience in 214 cases and cure rates according to current consensus criteria. Hazer DB, Işık S, Berker D, Güler S, Gürlek A, Yücel T, Berker M. J Neurosurg; 2013 Dec; 119(6):1467-77. PubMed ID: 24074496 [Abstract] [Full Text] [Related]
7. Outcomes after a purely endoscopic transsphenoidal resection of growth hormone-secreting pituitary adenomas. Campbell PG, Kenning E, Andrews DW, Yadla S, Rosen M, Evans JJ. Neurosurg Focus; 2010 Oct; 29(4):E5. PubMed ID: 20887130 [Abstract] [Full Text] [Related]
8. Pure endoscopic transsphenoidal surgery for treatment of acromegaly: results of 67 cases treated in a pituitary center. Gondim JA, Almeida JP, de Albuquerque LA, Gomes E, Schops M, Ferraz T. Neurosurg Focus; 2010 Oct; 29(4):E7. PubMed ID: 20887132 [Abstract] [Full Text] [Related]
10. Predictors of postoperative biochemical remission in lower Knosp grade growth hormone-secreting pituitary adenomas: a large single center study. Zhang S, Chen J, Yao S, Akter F, Wang Z, Hu B, Zhu D, Duan C, Chen W, Zhu Y, Wang H, Mao Z. J Endocrinol Invest; 2023 Mar; 46(3):465-476. PubMed ID: 36125731 [Abstract] [Full Text] [Related]
11. Prolonged preoperative treatment of acromegaly with Somatostatin analogs may improve surgical outcome in patients with invasive pituitary macroadenoma (Knosp grades 1-3): a retrospective cohort study conducted at a single center. Duan L, Zhu H, Xing B, Gu F. BMC Endocr Disord; 2017 Sep 06; 17(1):55. PubMed ID: 28874187 [Abstract] [Full Text] [Related]
12. Predictors of surgical outcome and early criteria of remission in acromegaly. Antunes X, Ventura N, Camilo GB, Wildemberg LE, Guasti A, Pereira PJM, Camacho AHS, Chimelli L, Niemeyer P, Gadelha MR, Kasuki L. Endocrine; 2018 Jun 06; 60(3):415-422. PubMed ID: 29626274 [Abstract] [Full Text] [Related]
13. Aggressive transsphenoidal resection of tumors invading the cavernous sinus in patients with acromegaly: predictive factors, strategies, and outcomes. Nishioka H, Fukuhara N, Horiguchi K, Yamada S. J Neurosurg; 2014 Sep 06; 121(3):505-10. PubMed ID: 25014437 [Abstract] [Full Text] [Related]
14. Effect of presurgical long-acting octreotide treatment in acromegaly patients with invasive pituitary macroadenomas: a prospective randomized study. Shen M, Shou X, Wang Y, Zhang Z, Wu J, Mao Y, Li S, Zhao Y. Endocr J; 2010 Sep 06; 57(12):1035-44. PubMed ID: 21099129 [Abstract] [Full Text] [Related]
15. Clinical, hormonal and magnetic resonance imaging (MRI) predictors of transsphenoidal surgery outcome in acromegaly. Bourdelot A, Coste J, Hazebroucq V, Gaillard S, Cazabat L, Bertagna X, Bertherat J. Eur J Endocrinol; 2004 Jun 06; 150(6):763-71. PubMed ID: 15191345 [Abstract] [Full Text] [Related]
16. Transsphenoidal surgery for acromegaly: predicting remission with early postoperative growth hormone assays. Sarkar S, Jacob KS, Pratheesh R, Chacko AG. Acta Neurochir (Wien); 2014 Jul 06; 156(7):1379-87; discussion 1387. PubMed ID: 24781680 [Abstract] [Full Text] [Related]
17. A follow-up study on outcomes of endoscopic transsphenoidal approach for acromegaly. Aydin S, Ozoner B, Sahin S, Alizada O, Comunoglu N, Oz B, Gazioglu N, Kadioglu P, Tanriover N. Clin Neurol Neurosurg; 2020 Nov 06; 198():106201. PubMed ID: 32927330 [Abstract] [Full Text] [Related]
18. Endoscopic endonasal approach for acromegaly: surgical outcomes using 2018 consensus criteria for remission. de Carvalho Cavalcante RA, Vieira LA, Peres LFA, Zaccariotti AJ, de Sousa Alencar H, Jatene EM, Camargo LA, Dias Rodrigues ML. Arch Endocrinol Metab; 2023 Jun 19; 67(6):e000650. PubMed ID: 37364152 [Abstract] [Full Text] [Related]
19. Evolving criteria for post-operative biochemical remission of acromegaly: can we achieve a definitive cure? An audit of surgical results on a large series and a review of the literature. Minniti G, Jaffrain-Rea ML, Esposito V, Santoro A, Tamburrano G, Cantore G. Endocr Relat Cancer; 2003 Dec 19; 10(4):611-9. PubMed ID: 14713271 [Abstract] [Full Text] [Related]
20. Surgical management of GH-secreting pituitary adenomas: an outcome study using modern remission criteria. Kreutzer J, Vance ML, Lopes MB, Laws ER. J Clin Endocrinol Metab; 2001 Sep 19; 86(9):4072-7. PubMed ID: 11549628 [Abstract] [Full Text] [Related] Page: [Next] [New Search]